Tagged Articles

C.R. Bard Inc. 3 articles

Resolution for nearly 50 women allegedly injured by transvaginal mesh

Law360 reports that this week close to 50 women have settled with C.R. Bard Inc. and agreed to end their lawsuits against the company. The lawsuits sought to hold Bard liable for injuries they say they sustained due to allegedly faulty transvaginal mesh implants. The suits were dismissed with prejudice from the pelvic mesh multidistrict litigation (MDL) by U.S. District Judge Joseph R. Goodwin, who is overseeing the seven separate MDLs in West Virginia. MDLs against the seven manufacturers of transvaginal mesh have been consolidated into one giant litigation with a total of around 70,000 pending cases. Law360 reports that according ... Read More

European authorities call for review of transvaginal mesh safety

European drug and medical device regulators have asked a scientific committee to review the safety of transvaginal mesh devices and whether the risks outweigh the benefits. The European Commission charged its Scientific Committee on Emerging and Newly Identified Health Risks to conduct the analysis on the surgical mesh products used to treat common pelvic floor disorders such as pelvic organ prolapse and stress urinary incontinence. The request is based on mounting reports of injuries associated with the devices, which range in severity and include complications such as rejection, tissue erosion, mesh exposure and shrinkage resulting in symptoms such as chronic ... Read More

Lawsuits mounting against manufacturers of transvaginal mesh

Nearly 500 lawsuits have been filed against two makers of vaginally implanted surgical mesh devices used to repair pelvic floor disorders by women who say the devices caused them serious internal injuries. The lawsuits have been filed against New Brunswick, New Jersey-based Johnson & Johnson, and C.R. Bard Inc. of Murray Hill, New Jersey. Transvaginal mesh is used to treat urinary incontinence or repair pelvic organ prolapse (POP) a common condition in women caused by childbirth, age and obesity. An estimated 75,000 women in 2010 received transvaginal mesh for POP repair or incontinence. The Food and Drug Administration (FDA) has received 1,503 reports ... Read More